Offstream
news

The Ghana Health Service says that over 700,000 people in the country has received their first dose of the AstraZeneca vaccine.
2021-04-12

Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.
2021-03-22

The World Health Organization announces the approval of the Oxford–AstraZeneca vaccine.
2021-02-15

Kyrgyzstan is expected to receive 504,000 doses of the Oxford-AstraZeneca vaccine in March.
2021-02-2

AstraZeneca’s vaccine candidate shows promise in older adults. Late-stage trials are expected to be released by Christmas.
2020-11-19

AstraZeneca and Johnson & Johnson resume their Phase III trials in the United States for a COVID-19 vaccine after previously pausing them as a result of complications with some volunteers.
2020-10-23

AstraZeneca announces that they would resume vaccine trials in Japan.
2020-10-2

AstraZeneca CEO Pascal Soriot says that the vaccine results could be ready by the end of the year if trials resume. Clinical trials were temporarily suspended after a participant in the trials began to develop symptoms associated with transverse myelitis.
2020-09-10

Prime Minister Scott Morrison announces a deal with CSL Limited to secure access to the COVID-19 vaccine being developed by AstraZeneca and receive the first batches of the potential vaccine in January.
2020-09-7

Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine.
2020-09-2